Little Green Pharma Ltd (ASX: LGP)
Australia
· Delayed Price · Currency is AUD 0.135
+0.010 (8.00%)
Dec 20, 2024, 4:10 PM AEST
Little Green Pharma Income Statement
Financials in millions AUD. Fiscal year is April - March.
Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2017 |
| Operating Revenue | 30.35 | 25.63 | 19.86 | 14.04 | 7 | 2.2 | Upgrade
|
| Other Revenue | -1.47 | - | - | - | - | - | Upgrade
|
| Revenue | 28.88 | 25.63 | 19.86 | 14.04 | 7 | 2.2 | Upgrade
|
| Revenue Growth (YoY) | 15.60% | 29.07% | 41.45% | 100.47% | 217.77% | 786.93% | Upgrade
|
| Cost of Revenue | 16.09 | 12.51 | 6.06 | 6.69 | 1.23 | 1.05 | Upgrade
|
| Gross Profit | 12.79 | 13.12 | 13.8 | 7.35 | 5.78 | 1.15 | Upgrade
|
| Selling, General & Admin | 15.93 | 15.96 | 19.52 | 25.66 | 8.21 | 7.74 | Upgrade
|
| Research & Development | 4.75 | 4.84 | 1.47 | 4.06 | -1.6 | 0.4 | Upgrade
|
| Operating Expenses | 21.27 | 20.8 | 20.98 | 29.72 | 6.61 | 8.15 | Upgrade
|
| Operating Income | -8.48 | -7.68 | -7.18 | -22.37 | -0.83 | -7 | Upgrade
|
| Interest Expense | -0.54 | -0.64 | -0.93 | -0.72 | -0.09 | -0.4 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.17 | 0.05 | 0.04 | 0.04 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | 0.01 | -0.56 | -1.35 | -0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.06 | 0.33 | 0.52 | 0.32 | Upgrade
|
| EBT Excluding Unusual Items | -8.86 | -8.14 | -8.56 | -24.07 | -0.38 | -7.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.02 | -0.02 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 22.59 | -2.29 | Upgrade
|
| Pretax Income | -9.43 | -8.15 | -8.56 | -24.07 | 22.22 | -9.32 | Upgrade
|
| Earnings From Continuing Operations | -9.43 | -8.15 | -8.56 | -24.07 | 22.22 | -9.32 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.65 | -0.31 | - | - | Upgrade
|
| Net Income | -9.43 | -8.15 | -9.21 | -24.38 | 22.22 | -9.32 | Upgrade
|
| Net Income to Common | -9.43 | -8.15 | -9.21 | -24.38 | 22.22 | -9.32 | Upgrade
|
| Shares Outstanding (Basic) | 301 | 300 | 250 | 236 | 154 | 128 | Upgrade
|
| Shares Outstanding (Diluted) | 301 | 300 | 250 | 236 | 166 | 128 | Upgrade
|
| Shares Change (YoY) | 7.78% | 19.91% | 5.90% | 42.33% | 29.56% | 84.85% | Upgrade
|
| EPS (Basic) | -0.03 | -0.03 | -0.04 | -0.10 | 0.14 | -0.07 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.03 | -0.04 | -0.10 | 0.13 | -0.07 | Upgrade
|
| Free Cash Flow | 2 | -0.65 | -8.76 | -33.07 | -6.05 | -12.37 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.00 | -0.04 | -0.14 | -0.04 | -0.10 | Upgrade
|
| Gross Margin | 44.27% | 51.18% | 69.50% | 52.38% | 82.47% | 52.31% | Upgrade
|
| Operating Margin | -29.37% | -29.98% | -36.16% | -159.33% | -11.90% | -317.41% | Upgrade
|
| Profit Margin | -32.65% | -31.81% | -46.35% | -173.66% | 317.20% | -422.66% | Upgrade
|
| Free Cash Flow Margin | 6.92% | -2.53% | -44.10% | -235.51% | -86.36% | -561.45% | Upgrade
|
| EBITDA | -5.84 | -5.02 | -4.35 | -21.06 | -0.35 | -6.85 | Upgrade
|
| EBITDA Margin | -20.24% | -19.57% | -21.90% | -150.01% | -5.01% | - | Upgrade
|
| D&A For EBITDA | 2.64 | 2.67 | 2.83 | 1.31 | 0.48 | 0.15 | Upgrade
|
| EBIT | -8.48 | -7.68 | -7.18 | -22.37 | -0.83 | -7 | Upgrade
|
| EBIT Margin | -29.37% | -29.98% | -36.16% | -159.33% | -11.90% | - | Upgrade
|
| Revenue as Reported | - | - | - | 14.04 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.